Home > Boards > US OTC > Biotechs >

Endonovo Therapeutics Inc. (ENDV)

Add ENDV Price Alert      Hide Sticky   Hide Intro
Moderator: brojazzy, Craig305
Search This Board: 
Last Post: 5/19/2022 7:45:43 PM - Followers: 186 - Board type: Free - Posts Today: 0

is a SCAM and full of DILUTION
The product, Sofpulse, is a viable product.  The CEO, Alan Collier only acquired the product to self enrich himself.  He does not care about shareholders.  He will not communicate with the shareholders.  Below is a list of PRs and their end results.
Aside from the below PRs, many PRs were made about distribution agreements and partnerships.  Nothing ever developed from those PRs.  Sales have not increased.

June 21, 2020 - Endonovo Therapeutics Announces Effectiveness of Registration of Equity Credit Line and Ceasing Variable Convertible Note Financing.
                          FALSE.  Dilution is still existant and eroding shareholder value.
March 25, 2020 - Endonovo Therapeutics seeks Intensive Care Unit Partners for Investigational Adjunctive Treatment for Severe Respiratory Inflammatory Complications for COVID-19 Patients.
                           They must still be seeking.  No news update. 
February 20, 2020 - Endonovo Therapeutics Begins Process For Medical Reimbursements
                           Begins is a very loose word.  Could mean reading about it.  No further action nor news has been released about this.
February 4, 2020 - Endonovo Therapeutics Reduces Debt
                          This was just moving preferred shares and then converting it to common shares and dumping into the float.
December 19, 2020 - Endonovo Therapeutics Announces Effective Date of Previously Announced Reverse Split of Common Stock
                         This split eroded all shareholder value due to continued dilution afterwards.  Company said they would never reverse split and not only performed one, did a very large one:  1000 to 1.
September 30, 2019 - Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO
                        No further news came after this.  Was probably paid for the use of his name only for the P.R.  
Early 2019 - Hires VP of Sales and a Chief Medical Office.  These positions are later eliminated with no PR.  Just swept under the rug.
Early 2019 - Initiates a patent lawsuit against 2 companies.  Both lawsuits were lost.
Early 2019  Shareholder letter - 
  • Signing two marketing agreements with well established medical device sales organizations  - (Nothing came from this.  Sales has been dismal then and continue to be just as bad).
    Establishment and expansion of a rapidly growing sales department  (Salespeople were hired, but sales never reached the level promised in a published PR).
    The completion of the purchase price to the seller of the SofPulse Technology  (Had no choice or lose the assets and patent.  The toxic noteholder has rights to the patent while ENDV needs to pay them back via dilution of common stock shares).
    The new Roma medical device is on schedule for release in Q1 of 2019  (The release never happened)


October 22, 2018 - Endonovo Therapeutics Provides Update on Liver Study
               This was a joke of a PR.  Fluff and no real data.
June 2018 - Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical™ Therapy
               This study is no longer happening.  The Doctor has moved on to his own new business.

All medical PRs and promises of further studies beyond 2017 developed into NOTHING!



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#32414  Sticky Note ENDONOVO THERAPEUTICS INC. (ENDV) is a SCAM and Craig305 01/01/22 06:30:43 PM
#31545  Sticky Note REVERSE STOCK SPLIT 1 FOR 1,000 BUYER BEWARE!!! Biotech_Tradez 10/31/19 11:54:37 AM
#32492   BUYER BEWARE: Share selling company, that’s all this is brojazzy 05/19/22 07:45:43 PM
#32491   BUYER BEWARE, CEO STOLE $1.3M IN STOCK! Biotech_Tradez 05/19/22 04:00:12 PM
#32490   Subsequent to March 31, 2022, the Board of Biotech_Tradez 05/19/22 03:59:25 PM
#32489   Q1 ER posted. 2.2k in revenue. LOL. That is Craig305 05/19/22 09:02:24 AM
#32488   So....CEO puts out a shareholder letter in October Craig305 05/18/22 03:25:05 PM
#32487   This pig is dead! Another RS coming your way brojazzy 05/16/22 07:16:51 PM
#32486   They will have an impossible task trying to Craig305 05/12/22 09:20:24 PM
#32485   I PREDICTED SUB-PENNY AGAIN AND LOW & BEHOLD! Biotech_Tradez 05/11/22 01:41:43 PM
#32484   Another 1,000 to 1 RS coming! Followed by Biotech_Tradez 05/11/22 01:41:02 PM
#32483   ENDV IN DEATH SPIRAL FINANCING!!! RUN!!! Biotech_Tradez 05/11/22 01:40:11 PM
#32482   Good luck selling shares at those prices! LOL Biotech_Tradez 05/11/22 01:39:42 PM
#32481   Reg A posting released today. https://ir.endonovo.com/all-sec-filings/content/0 Craig305 05/10/22 07:33:37 PM
#32480   Collier destroying his shareholders, as usual! What a brojazzy 05/09/22 08:39:08 PM
#32479   He better start the filing of the Pre Craig305 05/05/22 12:16:46 PM
#32478   Down 48% and officially sub-penny again. Thanks Collier Biotech_Tradez 05/05/22 11:48:26 AM
#32477   This POS should go to zero after the Biotech_Tradez 05/03/22 12:12:51 PM
#32476   The poor seller with 415k shares for sale Craig305 05/03/22 11:51:46 AM
#32475   Looks like ENDV will need another reverse split Craig305 05/03/22 11:24:32 AM
#32474   Endonovo Therapeutics Signs Agreement with NAMSA to Develop Craig305 04/25/22 11:37:16 AM
#32473   The quarterly earnings are not broken down in Biotech_Tradez 04/22/22 02:20:47 PM
#32472   Take a look at the quarterly financials on retired early 04/22/22 12:52:07 PM
#32471   What company are you looking at? ENDV had Biotech_Tradez 04/22/22 12:43:40 PM
#32470   Revenue 316 DOWN 97.25% retired early 04/22/22 12:00:28 PM
#32469   People need to report him to FINRA and Biotech_Tradez 04/22/22 12:17:24 AM
#32468   That piece of shit should be in prison brojazzy 04/21/22 10:11:04 PM
#32467   So he's looking for $5 million dollars. Who's retired early 04/19/22 02:35:03 PM
#32466   ENDV CEO Magically Ends Up with 16% of Biotech_Tradez 04/14/22 03:25:05 PM
#32465   Not the same guy. Biotech_Tradez 04/14/22 03:23:48 PM
#32464   You notice Tucker Anderson as a large shareholder Craig305 04/14/22 02:18:16 PM
#32463   ENDV CEO GIVES AWAY $1.2 MILLION IN STOCK Biotech_Tradez 04/14/22 02:00:38 PM
#32462   149,527,538 Shares outstanding - Dilution at Full Speed Biotech_Tradez 04/14/22 01:59:54 PM
#32461   Subsequent to December 31, 2021, the Board of Biotech_Tradez 04/14/22 01:59:14 PM
#32460   Sales tank, more debt, more fraud Biotech_Tradez 04/14/22 01:57:37 PM
#32459   10K posted. Lower sales and increased debt. Craig305 04/14/22 11:07:26 AM
#32458   ENDV has dangled the APAC sales territory for Craig305 04/11/22 01:15:52 PM
#32457   MORE FAKE NEWS TO SUPPORT THE DILUTION Biotech_Tradez 04/11/22 12:42:06 PM
#32456   ENDV will be late with the year end Craig305 03/31/22 05:06:17 PM
#32455   Current dilution about to take this to a Craig305 03/31/22 10:39:28 AM
#32454   That poor nude mouse. :( retired early 03/25/22 01:35:28 PM
#32453   Market maker PAUL selling newly issued shares into Craig305 03/24/22 01:24:35 PM
#32452   Endonovo's website now lists....Garry Michael Kann – Head Craig305 03/17/22 04:04:43 PM
#32451   This turd is done, thank the scam mgmt brojazzy 03/14/22 09:46:43 PM
#32450   Great post Craig, we can't forget that sales king koopa 02/27/22 10:13:41 PM
#32449   Is this scam still trading? brojazzy 02/23/22 08:03:45 AM
#32448   The only reason people bought shares recently was Craig305 02/19/22 07:25:12 PM
#32447   Does this company have any business other than John_Vallay 02/18/22 12:48:38 PM
#32446   Someone spent spent $38 to make ENDV appear Craig305 02/18/22 09:33:28 AM
#32444   Good. Now all you have to do is cruecu 02/16/22 07:59:18 PM
#32443   Dalmore Group? They are top notch! I know yerboss 02/16/22 07:08:43 PM
#32442   Endonovo Therapeutics Inc. (ENDV) Announces it has filed Craig305 02/16/22 12:44:26 PM
Consent Preferences